174 related articles for article (PubMed ID: 11355274)
1. Cilostazol: a novel treatment option in intermittent claudication.
Cariski AT
Int J Clin Pract Suppl; 2001 Apr; (119):11-8. PubMed ID: 11355274
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.
Thompson PD; Zimet R; Forbes WP; Zhang P
Am J Cardiol; 2002 Dec; 90(12):1314-9. PubMed ID: 12480040
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol: a review of its use in intermittent claudication.
Chapman TM; Goa KL
Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol for intermittent claudication.
Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
[TBL] [Abstract][Full Text] [Related]
5. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication.
Samra SS; Bajaj P; Vijayaraghavan KS; Potdar NP; Vyas D; Devani RG; Ballary C; Desai A
J Indian Med Assoc; 2003 Sep; 101(9):561-2, 564. PubMed ID: 15168999
[TBL] [Abstract][Full Text] [Related]
8. New treatment options in intermittent claudication: the US experience.
Hiatt WR
Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
[TBL] [Abstract][Full Text] [Related]
9. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
Dawson DL; Cutler BS; Hiatt WR; Hobson RW; Martin JD; Bortey EB; Forbes WP; Strandness DE
Am J Med; 2000 Nov; 109(7):523-30. PubMed ID: 11063952
[TBL] [Abstract][Full Text] [Related]
10. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
11. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.
Lee TM; Su SF; Hwang JJ; Tseng CD; Chen MF; Lee YT; Wang SS
Atherosclerosis; 2001 Oct; 158(2):471-6. PubMed ID: 11583728
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol: improving walking distance in patients with intermittent claudication.
Collinson DJ; Donnelly R
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110
[TBL] [Abstract][Full Text] [Related]
13. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol.
Sorkin EM; Markham A
Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol: treatment of intermittent claudication.
Reilly MP; Mohler ER
Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
[TBL] [Abstract][Full Text] [Related]
16. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
Strandness DE; Dalman RL; Panian S; Rendell MS; Comp PC; Zhang P; Forbes WP
Vasc Endovascular Surg; 2002; 36(2):83-91. PubMed ID: 11951094
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
18. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
Smith JA
Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
20. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
de Albuquerque RM; Virgini-Magalhães CE; Lencastre Sicuro F; Bottino DA; Bouskela E
Angiology; 2008; 59(5):549-58. PubMed ID: 18388031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
